Improve walking balance via aquatherapy

Trial ID
NCT07390825
Official Title
Evaluation of the Effects of Aquatic Therapy on Activities of Daily Living, Walking, Balance, Posture, Pain, and Depression in Parkinson's Patients
Goal
Improve walking balance via aquatherapy
Phase
NA
Status
RECRUITING
Sponsor
Ankara City Hospital Bilkent
Study Type
INTERVENTIONAL
Enrollment
42 participants
Conditions
Parkinson Disease
Interventions
Aquatherapy, home exercise

Summary For Families

The goal is to see whether regular aquatic therapy can improve daily activities, walking, balance, posture, pain, and depression in people with mild to moderate Parkinson's. Participants get supervised aquatic therapy in warm water, where buoyancy reduces joint load and fall risk, gentle water resistance helps strengthen muscles and practice gait and balance, and the soothing environment can ease pain and lift mood; this is a physical therapy approach that complements, and does not interact with, usual medications like levodopa. The trial is looking for adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, on a stable medication plan for at least 3 months, cognitively able (MMSE 24+), and able to stand and walk with or without assistance.

Locations

  • Bilkent City Hospital, Çankaya, Ankara, Turkey (Türkiye)
  • Bilkent City Hospital, Ankara, ÇANKAYA, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Aquatherapy. The goal is to see whether regular aquatic therapy can improve daily activities, walking, balance, posture, pain, and depression in people with mild to moderate Parkinson's. Participants get supervised aquatic therapy in warm water, where buoyancy reduces joint load and fall risk, gentle water resistance helps strengthen muscles and practice gait and balance, and the soothing environment can ease pain and lift mood; this is a physical therapy approach that complements, and does not interact with, usual medications like levodopa. The trial is looking for adults 40 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages 1 to 3, on a stable medication plan for at least 3 months, cognitively able (MMSE 24+), and able to stand and walk with or without assistance.
Who can participate?
Participants must be between 40 Years and 80 Years.
Where is this trial located?
This trial is recruiting at 2 locations.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 1 year and 7 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov